Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017598HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017499HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017500HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017750HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017706HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017631HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017943HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018561HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10012324HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10013109HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB00493
Drug NameCefotaxime
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs19164148
CitationsBaneres-Roquet F, Gualtieri M, Villain-Guillot P, Pugniere M, Leonetti JP: Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions. Antimicrob Agents Chemother. 2009 Apr;53(4):1528-31. doi: 10.1128/AAC.00971-08. Epub 2009 Jan 21.
GroupsApproved
Direct ClassificationCephalosporin 3'-esters
SMILES[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)C1=CSC(N)=N1)C(O)=O
Pathways
PharmGKBPA448852
ChEMBLCHEMBL1730